Literature DB >> 6270005

Re-evaluation of a transforming strain of Epstein-Barr virus from the Burkitt lymphoma cell line, Jijoye.

T Sairenji, Y Hinuma.   

Abstract

The biological properties of Epstein-Barr virus (EBV) from a Burkitt lymphoma cell line, Jijoye, were examined. the synthesis of virus capsid antigen (VCA) and early antigen (EA) in Jijoye cells was markedly enhanced by shift-down of the temperature of incubation from 37 degrees C to 33 degrees C. Cultures of Jijoye cells at 33 degrees C released a large amount of transforming EBV (10(5.2) of 50% transforming doses/ml) into the culture fluid. However, no infectious virus was produced in all cultures at 37 degrees C during the course of this study. The EBV (Jijoye EBV) from Jijoye line was found to possess only transforming activity, but not EA-inducing activity. Jijoye EBV lacks adsorbing capacity to Jijoye cells, in contrast to P3HR-I EBV which can adsorb to Jijoye cells. The Jijoye cells were highly susceptible to superinfection with P3HR-I EBV as demonstrated by the induction of EA, VCA and infectious EBV. The EBV induced by the P3HR-I EBV superinfection of Jijoye cells has also transforming activity but neither EA-inducing activity nor adsorbing capacity to Jijoye cells.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6270005     DOI: 10.1002/ijc.2910260313

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  10 in total

1.  Inhibition of Epstein-Barr virus (EBV) release from P3HR-1 and B95-8 cell lines by monoclonal antibodies to EBV membrane antigen gp350/220.

Authors:  T Sairenji; G Bertoni; M M Medveczky; P G Medveczky; Q V Nguyen; R E Humphreys
Journal:  J Virol       Date:  1988-08       Impact factor: 5.103

2.  Detection of circular and linear herpesvirus DNA molecules in mammalian cells by gel electrophoresis.

Authors:  T Gardella; P Medveczky; T Sairenji; C Mulder
Journal:  J Virol       Date:  1984-04       Impact factor: 5.103

3.  The interaction of mitogen-activated protein kinases to Epstein-Barr virus activation in Akata cells.

Authors:  T Satoh; Y Hoshikawa; Y Satoh; T Kurata; T Sairenji
Journal:  Virus Genes       Date:  1999       Impact factor: 2.332

4.  Complete nucleotide sequence of bean pod mottle virus RNA1: sequence comparisons and evolutionary relationships to other comoviruses.

Authors:  R Di; C C Hu; S A Ghabrial
Journal:  Virus Genes       Date:  1999       Impact factor: 2.332

5.  Epstein-Barr virus nuclear protein 2 (EBNA2) binds to a component of the human SNF-SWI complex, hSNF5/Ini1.

Authors:  D Y Wu; G V Kalpana; S P Goff; W H Schubach
Journal:  J Virol       Date:  1996-09       Impact factor: 5.103

6.  Deletion of the nontransforming Epstein-Barr virus strain P3HR-1 causes fusion of the large internal repeat to the DSL region.

Authors:  G W Bornkamm; J Hudewentz; U K Freese; U Zimber
Journal:  J Virol       Date:  1982-09       Impact factor: 5.103

7.  Non-immortalizing P3J-HR-1 Epstein-Barr virus: a deletion mutant of its transforming parent, Jijoye.

Authors:  M Rabson; L Gradoville; L Heston; G Miller
Journal:  J Virol       Date:  1982-12       Impact factor: 5.103

8.  Analysis of the transformation of human lymphocytes by Epstein-Barr virus III. Induction of early events by P3HR-1 strain without subsequent immortalization.

Authors:  K Takada; T Osato
Journal:  Med Microbiol Immunol       Date:  1981       Impact factor: 3.402

9.  Epstein-Barr Virus Lytic Reactivation Activates B Cells Polyclonally and Induces Activation-Induced Cytidine Deaminase Expression: A Mechanism Underlying Autoimmunity and Its Contribution to Graves' Disease.

Authors:  Keiko Nagata; Keisuke Kumata; Yuji Nakayama; Yukio Satoh; Hirotsugu Sugihara; Sayuri Hara; Michiko Matsushita; Satoshi Kuwamoto; Masako Kato; Ichiro Murakami; Kazuhiko Hayashi
Journal:  Viral Immunol       Date:  2017-03-23       Impact factor: 2.257

10.  Epstein-Barr Virus Lytic Reactivation Induces IgG4 Production by Host B Lymphocytes in Graves' Disease Patients and Controls: A Subset of Graves' Disease Is an IgG4-Related Disease-Like Condition.

Authors:  Keiko Nagata; Sayuri Hara; Yuji Nakayama; Katsumi Higaki; Hirotsugu Sugihara; Satoshi Kuwamoto; Michiko Matsushita; Masako Kato; Shunsuke Tanio; Kiyosuke Ishiguro; Kazuhiko Hayashi
Journal:  Viral Immunol       Date:  2018-09-17       Impact factor: 2.257

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.